Mark Augusti
Chief Executive Officer bei AdvaMed Accel
Vermögen: - $ am 30.09.2023
Profil
Mark A.
Augusti is the President, Chief Executive Officer & Director of AdvaMed Accel.
He was previously the President, Chief Executive Officer & Director of ConforMIS, Inc. from 2016 to 2023, and the President & Chief Executive Officer of Bioventus LLC in 2012-2013.
He served as an Independent Director at Hutchinson Technology, Inc. from 2011 to 2012.
From 2014 to 2016, he was the VP, President-Orthopedics & Tissue Technologies at Integra LifeSciences Holdings Corp.
He was also a Vice President at JPMorgan Chase & Co. in 2003.
From 2003 to 2012, he was the President-Biologics & Clinical Therapies at Smith & Nephew plc.
Augusti received his undergraduate degree from Duke University and his MBA from UCLA Anderson School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CONFORMIS INC
-.--% | 05.09.2023 | 0 ( -.--% ) | - $ | 30.09.2023 |
Aktive Positionen von Mark Augusti
| Unternehmen | Position | Beginn |
|---|---|---|
AdvaMed Accel
 AdvaMed Accel Miscellaneous Commercial ServicesCommercial Services Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The private company is based in Washington. The CEO of the American company is Mark A. Augusti. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Mark Augusti
| Unternehmen | Position | Ende |
|---|---|---|
| CONFORMIS, INC. | Chief Executive Officer | 05.09.2023 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Corporate Officer/Principal | 11.11.2016 |
| HUTCHINSON TECHNOLOGY INCORPORATED | Director/Board Member | 09.05.2012 |
| SMITH & NEPHEW PLC | Corporate Officer/Principal | 01.04.2012 |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Mark Augusti
| Duke University | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| JPMORGAN CHASE & CO. | Finance |
| SMITH & NEPHEW PLC | Health Technology |
| CONFORMIS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Hutchinson Technology, Inc.
 Hutchinson Technology, Inc. Electronic Production EquipmentElectronic Technology Hutchinson Technology, Inc. engages in the design and manufacture of products that require chemical, mechanical, and electronic technologies. It offers optical image stabilization, custom precision components, screens, circuits, micro assembly, hard disk drive suspensions, and sensors. The company was founded by Jon A. Geiss and Jeffrey W. Green in 1965 and is headquartered in Hutchinson, MN. | Electronic Technology |
Bioventus LLC
 Bioventus LLC Medical SpecialtiesHealth Technology Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC. | Health Technology |
AdvaMed Accel
AdvaMed Accel Miscellaneous Commercial ServicesCommercial Services Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The private company is based in Washington. The CEO of the American company is Mark A. Augusti. | Commercial Services |
